Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. (VRDN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
vrdn · stock forecast · 16 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 16 Wall Street analysts in the past 3 months
Buy
16 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$50.00
Consensus
$36.86
+134.3% upside
Low
$26.00
Median: $34 · Last Close: $15.73
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$36.86
134.3% upside
High Target
$50
217.9%
Low Target
$26
65.3%
Current Price
$15.73
as of today
Based on analyst price targets, the VRDN stock price prediction for the next 12 months ranges from $26 to $50. The consensus VRDN price forecast of $36.86 implies 134.3% upside from the current price of $15.73.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $15.11 | ↓ 3.96% |
1-day model range: $14.85–$15.36. Peak: $15.36 (-3.96%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $14 | -9.3% |
| 2028 | $14 | -13.9% |
| 2029 | $13 | -16.3% |
| 2030 | $13 | -17.6% |
| 2031 | — | -18.3% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · VRDN · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-05-06 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-05 | Needham | Maintains | Buy→Buy |
| 2026-04-21 | Truist Securities | Maintains | Buy→Buy |
| 2026-04-08 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-07 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-04-07 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-04-02 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-03-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-31 | Goldman Sachs | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Viridian Therapeutics, Inc. (VRDN) stock. Of the recent 114 rating actions, 0 were upgrades and 3 were downgrades. 16 analysts currently cover VRDN.
Analyst Recommendation Trends
VRDN analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$46M
↓ 92.1% YoY
Revenue Next Year
$244M
↑ 431.1% YoY
EPS This Year
$-3.77
EPS Next Year
$-2.42
↓ 35.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast VRDN EPS of $-3.77 for the current fiscal year, based on estimates from 10 analysts. The VRDN revenue forecast is $46M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The VRDN stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus VRDN price target is $36.86 (+134.3% upside), with an analyst consensus of Buy.
The VRDN short-term stock prediction for tomorrow is $15.11 (-3.96%). The VRDN stock price prediction for 2027 estimates an average of $14. The VRDN stock prediction for 2030 projects a range of $11–$15.
Viridian Therapeutics, Inc. trades on NASDAQ under the ticker VRDN. The VRDN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 81% of covering analysts.
Frequently asked questions
VRDN forecast · 8 questionsAccording to 16 Wall Street analysts, the average 12-month VRDN price target is $36.86, with a high forecast of $50.00 and a low of $26.00. The median price target is shown in the chart above when available. This implies +134.3% potential upside from the current price of $15.73.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.